IL2 and neoplasm: Tumor models of miR-21 knock-in mice treated with anti-PD-L1 antibody and radiation resulted in increased T-cell, IFN-γ, IL-2, and reduced tumor size coupled to a decreased PD-L1 expression, thus improving immunotherapy via T-cell immune response activation (Guo et al. 2022).